Abiopharma

🔍 Kim Jae (Executive)

Company: Lumentum Holdings Inc. (LITE)

Report Date: 2026-08-19

Detailed Transactions and Holdings:

• Sold 1,973 shares of Common Stock at $827.6 per share (Direct)
  Date: 2026-08-19 | Code: F | equity_swap_involved: 0 | shares_owned_after: 44,000.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,904 shares of Common Stock at $827.82 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 42,096.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 3,926 shares of Common Stock at $866.71 per share (Direct)
  Date: 2026-08-21 | Code: F | equity_swap_involved: 0 | shares_owned_after: 38,170.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents shares that have been withheld by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting of restricted stock units.
• F2: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 6, 2026.